TotalMarketCap

BioNTech SE

BNTXNasdaq GermanyHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$24.528 B

$97.64 +0.76%

Close of 6 Oct 2026

As of 6 Oct 2026, BioNTech SE (BNTX) has a market capitalization of $24.5B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

251,204,366

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 160 →
  1. #5Revolution MedicinesRVMD$44.5B
  2. #6BiogenBIIB$33.0B
  3. #7BioNTech SEBNTX$24.5B
  4. #8Neurocrine BiosciencesNBIX$14.7B
  5. #9ExelixisEXEL$14.6B

What if BioNTech SE were worth as much as…

Open the what-if tool →

Gold $28.8T

$114,770.73

Per share 1,175× higher

Bitcoin $1.68T

$6,700.14

Per share 68.6× higher

Nvidia $5.76T

$22,919.55

Per share 235× higher

Or at a round number

$50.0B$100.0B$200.0B$500.0B

Where these numbers come from

Share counts and financials for BioNTech SE are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 7 Oct 2026. Read the methodology.